11/29/2011 -   Odyssey Thera is First to Install Next Generation High-Content Imaging Capability 05/04/2011 -   Odyssey Thera Awarded 19th Patent for Drug Discovery and Re-Purposing Technologies 01/05/2011 -   Odyssey Thera Announces U.S. Patent for Technologies Enabling Protein Interaction Screening and Directed Evolution 12/03/2010 -   Odyssey Thera to Participate in Expanded EPA Initiative 06/22/2010 -   Odyssey Thera Awarded Contract from the United States Environmental Protection Agency 05/05/2010 -   Pfizer, Inc. and Odyssey Thera Inc. co-publish manuscript describing oncology therapeutic candidate 03/09/2010 -   Odyssey Thera announces agreement with Lonza 10/07/2009 -   Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones 05/15/2009 -   Odyssey Thera Announces Collaboration with Mitsubishi Tanabe Pharma Corporation, and Issuance of Core Patent in Japan 02/12/2009 -   ODYSSEY THERA GRANTED U.S. PATENT FOR NOVEL GPCR ASSAY STRATEGY 10/07/2008 -   Odyssey Thera Announces New Equity Financing 08/07/2008 -   Odyssey Thera Announces Milestone Achievement in Pfizer Alliance 12/13/2007 -   ODYSSEY THERA RECEIVES MILESTONE PAYMENTS IN PFIZER COLLABORATION 12/12/2007 -   ODYSSEY THERA GRANTED U.S. PATENT FOR ANIMAL IMAGING 04/23/2007 -   FDA Forum on Drug Discovery, Development and Translation Presentation by Odyssey Thera’s President and CSO 04/10/2007 -   ODYSSEY THERA ANNOUNCES COLLABORATION WITH ABBOTT 02/02/2007 -   ODYSSEY THERA GRANTED TWO MORE U.S. PATENTS FOR ITS PATHWAY-BASED DRUG DISCOVERY STRATEGY 10/31/2006 -   Hugh Y. Rienhoff, Jr., M.D., Joins Odyssey Thera’s Board of Directors 09/05/2006 -   Odyssey Thera Announces a Major Multi-year Collaboration with Pfizer 06/20/2006 -   ODYSSEY THERA GRANTED U.S. PATENT FOR PATHWAY-BASED DRUG DISCOVERY STRATEGY 05/07/2006 -   Publication Describes Novel Strategy for Discovering Safe and Effective Drugs 09/30/2005 -   Odyssey Thera Establishes The World’s Largest Collection Of High-Content Assays 08/18/2005 -   Odyssey Thera Awarded First European Patent for PCA Technology 08/17/2005 -   National Institutes of Health (NIH) signs agreement with Odyssey Thera, Inc. 07/14/05 -   Bristol Myers Squibb Initiates Project with Odyssey Thera, Inc. 06/20/2005 -   Lexicon Genetics Inc. Initiates Project with Odyssey Thera 06/13/2005 -   Odyssey Thera Awarded Fifth and Sixth Patents for PCA Technology 05/17/2005 -   Odyssey Thera Expands Project with Pfizer Inc. 12/08/2004  -   Odyssey Thera Awarded Fourth Patent for PCA Technology 10/19/2004 -   Odyssey Thera, Inc. Announces Exclusive License for Breakthrough Technology to Panbio Limited (Australia) 10/08/2004 -   Merck & Co., Inc. Expands Project with Odyssey Thera, Inc. 04/08/2004 -   Odyssey Thera Initiates Project with F. Hoffmann-La Roche Ltd 11/25/2003 -   Odyssey Thera Initiates Project with Pfizer Inc. 09/15/2003 -   Odyssey Thera and Dharmacon Announce Collaboration 8/20/2003 -   Kleanthis G. Xanthopoulos, Ph.D. Joins Odyssey Thera’s Board of Directors 1/20/03 -   Odyssey Thera (formerly Odyssey Pharmaceuticals) appoints John Westwick, Ph. D. as Vice President of Drug Discovery 9/9/2002 -   Odyssey Pharmaceuticals Awarded Third Patent for PCA Technology 8/8/2002 -   Novel in vivo and in vitro sensors of protein-protein interactions 6/24/2002 -   Odyssey Completes $15 Million Series B Financing 12/10/2001 -   Odyssey Scientists Visualize TNF Response Pathway in Living Cells 9/28/2001 -   Odyssey Pharmaceuticals Awarded Second Patent for Target Validation and Drug Discovery Platform 8/7/2001 -   Odyssey Pharmaceuticals awarded key patent for platform technology 8/3/2001 -   Direct visualization of protein interactions in plant cells 7/5/2001 -   Revolutionary technology enables dynamic visualization of protein function in living cells 6/25/2001 -   C. Thomas Caskey, M.D. Joins Odyssey Pharmaceuticals Board of Directors 5/9/2001 -   Incyte Genomics and Odyssey Pharmaceuticals Announce Collaboration to Functionally Annotate Human Proteins